Data as of Dec 06
| +0.09 / +0.43%|
The 6 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 26.50, with a high estimate of 29.00 and a low estimate of 23.00. The median estimate represents a +26.79% increase from the last price of 20.90.
The current consensus among 6 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.